74733-23-6

Basic information

• Product Name: Methyl 4-forMyl-2-Methylbenzoate
• Synonyms: Methyl 4-forMyl-2-Methylbenzoate
• CAS NO: 74733-23-6
• Molecular Formula: C₁₀H₁₀O₃
• Molecular Weight: 178.1846
• Mol File: 74733-23-6.mol

Chemical Properties

• Boiling Point: 288.2±28.0 °C(Predicted)
• Appearance: /
• Density: 1.147±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Methyl 4-forMyl-2-Methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-forMyl-2-Methylbenzoate(74733-23-6)
• EPA Substance Registry System: Methyl 4-forMyl-2-Methylbenzoate(74733-23-6)

Safety Data

• Hazardous Substances Data: 74733-23-6(Hazardous Substances Data)

Usage

Uses

Used in Perfumery and Fragrance Industry:
Methyl 4-formyl-2-methylbenzoate is used as a fragrance ingredient for its appealing and fruity scent, contributing to the development of various perfumes and fragrances.
Used in Food and Beverage Industry:
In the food and beverage sector, Methyl 4-formyl-2-methylbenzoate serves as a flavoring agent, enhancing the taste and aroma of different products.
Used in Pharmaceutical Industry:
Methyl 4-formyl-2-methylbenzoate is utilized as an intermediate in the synthesis of pharmaceuticals, playing a crucial role in the production of various organic compounds.
Safety Precautions:
It is essential to handle Methyl 4-formyl-2-methylbenzoate with care due to its potential to cause skin and eye irritation. Proper storage and usage in well-ventilated areas are recommended to ensure safety during its application in various industries.

Upstream product

• 67-56-1 methanol 
• 503470-23-3 4-formyl-2-methylbenzoic acid 
• 201230-82-2 carbon monoxide 
• 78775-11-8 3-methyl-4-bromobenzaldehyde 
• 74-88-4 methyl iodide 
• 99548-55-7 4-bromo-2-methyl-benzoic acid methyl ester 
• 141-53-7 sodium formate 
• 103261-67-2 4-cyano-2-methylbenzoic acid methyl ester 
• 68837-59-2 4-bromo-2-methylbenzoic acid 
• 530145-28-9 methyl 4-(hydroxymethyl)-2-methylbenzoate 

Downstream Products

• 959801-04-8 4-[({6-[5-isopropyl-3-(2-trifluoromethoxy-phenyl)-3H-[1,2,3]triazol-4-ylmethoxy]-2-methyl-pyridin-3-yl}-methyl-amino)-methyl]-2-methyl-benzoic acid methyl ester 
• 959632-51-0 4-({[4-(tert-butyl-dimethyl-silanyloxy)-2-methyl-phenyl]-methyl-amino}-methyl)-2-methyl-benzoic acid methyl ester 
• 1261169-50-9 methyl 4-((hydroxyimino)methyl)-2-methylbenzoate 
• 503470-23-3 4-formyl-2-methylbenzoic acid 
• 959801-08-2 4-[({4-[3-(2,6-dichlorophenyl)-5-trifluoromethyl-3H-[1,2,3]triazol-4-ylmethoxy]-2-methylphenyl}-methylamino)-methyl]-2-methyl-benzoic acid methyl ester 
• 959632-53-2 4-{[(4-hydroxy-2-methyl-phenyl)-methyl-amino]-methyl}-2-methyl-benzoic acid methyl ester 

Relevant articles and documents

Synthesis of novel EP4 antagonists and their use in cancer and inflammation

The present invention relates to a compound capable of effectively antagonizing EP4, which is a compound represented by formula I, or a tautomer, a stereoisomer, a hydrate, a solvate, a pharmaceutically-acceptable salt or a prodrug of the compound represented by formula I. R1 is selected from -CH3, -CHF2, and -CF3; R2 is selected from C2-C6 alkyl, C3-C6 cycloalkyl, halogenated C2-C6 alkyl, and halogenated C3-C6 cycloalkyl; R3 is selected from hydrogen, halogen, C1-C2 alkyl, and fluorinated C1-C2 alkyl; R4 is selected from hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkyl, and halogenated C1-C6 alkoxy.

PYRIMIDO[5,4-d]PYRIMIDINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS

The present invention relates to pyrimido[5,4-d]pyrimidine derivatives of formula (I), including pharmaceutically acceptable salts and solvates thereof. Compounds of the invention are inhibitors of ENT family transporter, especially of ENT1, and are useful as therapeutic compounds for the treatment of cancers. The invention also relates to the combined use of the pyrimido[5,4-d]pyrimidine derivatives with an adenosine receptor antagonist, for the treatment of cancers.

ISOXAZOLINE DERIVATIVES AS PESTICIDES

The present invention provides compounds of formula (I): which are useful for long-lasting treatment and control of pests, for example fleas and ticks, in companion animals and livestock, and pharmaceutical compositions and methods of using the same.

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

INHIBITORS OF HEPATITIS C VIRUS POLYMERASE

The present invention provides, among other things, compounds represented by the general Formula I: (I) and pharmaceutically acceptable salts thereof, wherein L and A (and further substituents) are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.

LSD1 INHIBITORS AND USES THEREOF

Provided are novel compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with LSDl. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with LSDl.

Modulators of methyl modifying enzymes, compositions and uses thereof

Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.

Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators

NMDA receptors are tetrameric complexes composed of GluN1 and GluN2A-D subunits that mediate a slow Ca2+-permeable component of excitatory synaptic transmission. NMDA receptors have been implicated in a wide range of neurological diseases and thus represent an important therapeutic target. We herein describe a novel series of pyrrolidinones that selectively potentiate only NMDA receptors that contain the GluN2C subunit. The most active analogues tested were over 100-fold selective for recombinant GluN2C-containing receptors over GluN2A/B/D-containing NMDA receptors as well as AMPA and kainate receptors. This series represents the first class of allosteric potentiators that are selective for diheteromeric GluN2C-containing NMDA receptors.

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein

INSECTICIDAL ARYL ISOXAZOLINE DERIVATIVES

The present invention relates to novel aryl isoxazoline derivatives having excellent insecticidal activity as insecticides and represented by the formula: and their use as insecticides and acarizides.